Neogen Corporation Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
Neogen Corporation (NEOG) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of $1.50 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-07-30
- Neogen Corporation effective income tax rate reconciliation, tax contingency, amount for fiscal 2026 was $1.50M.
- Neogen Corporation effective income tax rate reconciliation, tax contingency, amount for fiscal 2021 was -$76.00K, a 128.25% decline from fiscal 2020.
- Neogen Corporation effective income tax rate reconciliation, tax contingency, amount for fiscal 2020 was $269.00K, a 1969.23% increase from fiscal 2019.
- Neogen Corporation effective income tax rate reconciliation, tax contingency, amount for fiscal 2019 was $13.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2026-05-31 | $1.50M 10-K · filed 2026-07-30 |
| 2021-05-31 | -$76.00K 10-K · filed 2021-07-30 |
| 2020-05-31 | $269.00K 10-K · filed 2021-07-30 |
| 2019-05-31 | $13.00K 10-K · filed 2021-07-30 |
| 2018-05-31 | -$1.03M 10-K · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |